Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations

L. Perrem (Toronto, Canada), S. Stanojevic (Toronto, Canada), M. Klingel (Toronto, Canada), S. Isaac (Toronto, Canada), R. Jensen (Toronto, Canada), M. Solomon (Toronto, Canada), H. Grasemann (Toronto, Canada), V. Waters (Toronto, Canada), N. Sweezey (Toronto, Canada), S. Davis (Chapel Hill, United States of America), F. Ratjen (Toronto, Canada)

Source: International Congress 2019 – Physiology of cystic fibrosis
Session: Physiology of cystic fibrosis
Session type: Poster Discussion
Number: 330
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Perrem (Toronto, Canada), S. Stanojevic (Toronto, Canada), M. Klingel (Toronto, Canada), S. Isaac (Toronto, Canada), R. Jensen (Toronto, Canada), M. Solomon (Toronto, Canada), H. Grasemann (Toronto, Canada), V. Waters (Toronto, Canada), N. Sweezey (Toronto, Canada), S. Davis (Chapel Hill, United States of America), F. Ratjen (Toronto, Canada). Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations. 330

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Source: Eur Respir J 2015; 46: 1055-1064
Year: 2015



Lung clearance index improves with treatment of an exacerbation in cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007



Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017
Year: 2018



Long-term course of lung clearance index among patients with cystic fibrosis
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020


Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Tracking pulmonary exacerbations in preschool children using the lung clearance index
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Impact of lung disease on respiratory impedance in young children with cystic fibrosis
Source: Eur Respir J 2015; 46: 1672-1679
Year: 2015



Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018



Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Lung clearance index and lung ultrasound in cystic fibrosis children
Source: International Congress 2018 – Cystic fibrosis: diagnosis and monitoring
Year: 2018

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
Source: Eur Respir J 2012; 40: 61-66
Year: 2012



Effect of azithromycin on FEV1 and exacerbation frequency in adult non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2007; 30: Suppl. 51, 528s
Year: 2007

Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 529s
Year: 2002

Longitudinal course of clinically measured lung clearance index in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia
Source: Eur Respir J 2016; 47: 829-836
Year: 2016



The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009